Riskpilot← Back to searchSign inGet full accessNYTORGET LEGESENTER AS
ASActiveOrg 997807537Klubbgata 5, 4013 StavangerGeneral medical practice activities · NACE 8621Est. 20128 employees
Revenue 2025
NOK 7M
+1% vs 2024
EBITDA margin
5.4%
+273% vs 2024
Equity ratio
40.9%
Financial strength
Net profit 2025
NOK 231K
+1178% vs 2024
| Revenue | NOK 7M | +1% |
| EBITDA | NOK 373K | +273% |
| Net profit | NOK 231K | +1178% |
| Total assets | NOK 2,4M | +56% |
| Equity | NOK 965K | +32% |
| Employees | 8 | — |
Legal name
NYTORGET LEGESENTER AS
Org number
997807537
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
9. januar 2012
Share capital
NOK 175 000
Employees
8 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Company purpose
Drift av legesenter- stille utstyr og personell til rådighet for leger tilknyttet senteret. Handel, hva dermed står i forbindelse ,samt deltakelse i andre selskaper med lignende formål.
Address
Klubbgata 5, 4013 Stavanger
Phone
+4751917080
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 5 533 | 5 820 | 6 564 | 6 916 | 6 956 |
| Staff expenses | −3 007 | −3 053 | −3 076 | −3 791 | −3 783 |
| EBITDA | 100 | 85 | 75 | 100 | 373 |
| Depreciation & amort. | −76 | −70 | −74 | −77 | −68 |
| EBIT | 24 | 15 | 1 | 23 | 305 |
| Net financials | −24 | −13 | 7 | −5 | −11 |
| Profit before tax | 0 | 2 | 8 | 18 | 293 |
| Tax | −0 | −0 | −0 | −0 | 62 |
| Net profit | 0 | 2 | 8 | 18 | 231 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 949 | 1 764 | 2 230 | 1 514 | 2 359 |
| Equity | 706 | 708 | 716 | 734 | 965 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 243 | 1 056 | 1 514 | 781 | 1 394 |
| Total debt | 1 243 | 1 056 | 1 514 | 781 | 1 394 |
EBITDA margin
5.4%
This company
15.8%
Market median
-66% vs market
20212025
Equity ratio
40.9%
This company
38.2%
Market median
+7% vs market
20212025
Return on equity
24.0%
This company
18.4%
Market median
+30% vs market
20212025
Net profit margin
3.3%
This company
8.1%
Market median
-59% vs market
20212025
Asset turnover
2.95×
This company
1.12×
Market median
+163% vs market
20212025
Debt / equity
1.44×
This company
0.62×
Market median
-132% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2023 | |
| Board of Directors | 2025 | |
| Former (1) | ||
| Board of Directors | 2019 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 12.57% | 12.57% | 2024 | |
| Individual | 12.57% | 12.57% | 2024 | |
| Individual | 12.57% | 12.57% | 2024 | |
| Individual | 12.57% | 12.57% | 2024 | |
| Individual | 12.57% | 12.57% | 2024 | |
| Individual | 12.57% | 12.57% | 2024 | |
| Individual | 12.57% | 12.57% | 2024 | |
| Individual | 12% | 12% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of NYTORGET LEGESENTER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Emina Veledar | Board of Directors | 0 companies |
| Kari Ersland | Board of Directors | 0 companies |
| Camilla Steinsbø | Board of Directors | 0 companies |